Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
7.85
-0.04 (-0.51%)
At close: Sep 5, 2025, 4:00 PM
7.86
+0.01 (0.13%)
After-hours: Sep 5, 2025, 7:49 PM EDT
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.27 billion as of September 5, 2025. Its market cap has increased by 212.78% in one year.
Market Cap
1.27B
Enterprise Value
1.47B
1-Year Change
212.78%
Ranking
Category
Stock Price
$7.85
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.27B, an increase of 328.57%. That is a compound annual growth rate of 45.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 1.27B | 152.10% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |